Favourable remission rate by repeating low dose ARA-C treatment in ANLL and RAEB.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000188:drug therapy*; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003561:Cytarabine